Prolacria FDA Approval Status

FDA Approved: No
Brand name: Prolacria
Generic name: diquafosol tetrasodium
Dosage form: Ophthalmic Solution
Company: Inspire Pharmaceuticals, Inc.
Treatment for: Dry Eye

Development timeline for Prolacria

Date	Article
Oct 5, 2006	Inspire Continues Discussions with FDA on Dry Eye Program
Mar 28, 2006	Inspire Announces Outcome of FDA Meeting on Dry Eye Program
Dec 2, 2005	Inspire Announces Receipt of FDA Approvable Letter for Diquafosol
Jun 1, 2005	Inspire Submits Amendment to New Drug Application for Diquafosol for the Treatment of Dry Eye
Jan 30, 2004	Inspire Pharmaceuticals Announces Outcome of Meeting with the FDA on Diquafosol

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer